Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001235118 | SCV001407788 | uncertain significance | Saldino-Mainzer syndrome | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 884 of the IFT140 protein (p.Arg884Gly). This variant is present in population databases (rs554196965, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. ClinVar contains an entry for this variant (Variation ID: 635439). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002487618 | SCV002783656 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2022-02-03 | criteria provided, single submitter | clinical testing | |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000786891 | SCV000925790 | likely pathogenic | Retinitis pigmentosa 80 | 2018-11-05 | no assertion criteria provided | clinical testing |